Clinical Trial Update: Apixaban Safety and Therapy Adherence in Patients With Atrial Fibrillation

View source ↗

Summary

A clinical trial is evaluating the safety and therapy adherence of apixaban in patients with nonvalvular atrial fibrillation; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nonvalvular Atrial Fibrillation

Drugs mentioned

• Apixaban (apixaban)

Snippet

Sponsor: Bosnalijek D.D | Conditions: Nonvalvular Atrial Fibrillation | Status: RECRUITING